BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9222376)

  • 21. Perforin-mediated effector function within the central nervous system requires IFN-gamma-mediated MHC up-regulation.
    Bergmann CC; Parra B; Hinton DR; Chandran R; Morrison M; Stohlman SA
    J Immunol; 2003 Mar; 170(6):3204-13. PubMed ID: 12626579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Population dynamics of lymphocyte subsets in the central nervous system of rats with different susceptibility to coronavirus-induced demyelinating encephalitis.
    Dörries R; Schwender S; Imrich H; Harms H
    Immunology; 1991 Nov; 74(3):539-45. PubMed ID: 1663079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selection of CD8+ T cells with highly focused specificity during viral persistence in the central nervous system.
    Marten NW; Stohlman SA; Smith-Begolka W; Miller SD; Dimacali E; Yao Q; Stohl S; Goverman J; Bergmann CC
    J Immunol; 1999 Apr; 162(7):3905-14. PubMed ID: 10201909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-magnitude, virus-specific CD4 T-cell response in the central nervous system of coronavirus-infected mice.
    Haring JS; Pewe LL; Perlman S
    J Virol; 2001 Mar; 75(6):3043-7. PubMed ID: 11222733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of CD4 and CD8 T cells in MHV-JHM-induced demyelination.
    Wu GF; Dandekar AA; Pewe L; Perlman S
    Adv Exp Med Biol; 2001; 494():341-7. PubMed ID: 11774490
    [No Abstract]   [Full Text] [Related]  

  • 26. Pathogenesis of acute and chronic central nervous system infection with variants of mouse hepatitis virus, strain JHM.
    Templeton SP; Perlman S
    Immunol Res; 2007; 39(1-3):160-72. PubMed ID: 17917063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative analysis of coronavirus JHM-induced demyelinating encephalomyelitis in Lewis and Brown Norway rats.
    Watanabe R; Wege H; ter Meulen V
    Lab Invest; 1987 Oct; 57(4):375-84. PubMed ID: 2444766
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta-endorphin protects mice from neurological disease induced by the murine coronavirus MHV-JHM.
    Gilmore W; Moradzadeh DS
    J Neuroimmunol; 1993 Oct; 48(1):81-90. PubMed ID: 8227310
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mouse hepatitis virus neurovirulence: evidence of a linkage between S glycoprotein expression and immunopathology.
    Rempel JD; Murray SJ; Meisner J; Buchmeier MJ
    Virology; 2004 Jan; 318(1):45-54. PubMed ID: 14972534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FTY720 (fingolimod) modulates the severity of viral-induced encephalomyelitis and demyelination.
    Blanc CA; Rosen H; Lane TE
    J Neuroinflammation; 2014 Aug; 11():138. PubMed ID: 25138356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of the intracerebral antibody response on the clinical course of a virus-induced demyelination in a rat model system.
    Dörries R; Imrich H; Hein A; Czub S; Schwender S
    J Neurol Neurosurg Psychiatry; 1994 Nov; 57 Suppl(Suppl):18-20. PubMed ID: 7964844
    [No Abstract]   [Full Text] [Related]  

  • 32. Role of viral persistence in retaining CD8(+) T cells within the central nervous system.
    Marten NW; Stohlman SA; Bergmann CC
    J Virol; 2000 Sep; 74(17):7903-10. PubMed ID: 10933698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of CTL mutants in demyelination induced by mouse hepatitis virus, strain JHM.
    Perlman S; Pewe L
    Adv Exp Med Biol; 1998; 440():515-9. PubMed ID: 9782323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigen specificity of CD4 T cell response in the central nervous system of mice infected with mouse hepatitis virus.
    Xue S; Perlman S
    Virology; 1997 Nov; 238(1):68-78. PubMed ID: 9375010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IFN-gamma is required for viral clearance from central nervous system oligodendroglia.
    Parra B; Hinton DR; Marten NW; Bergmann CC; Lin MT; Yang CS; Stohlman SA
    J Immunol; 1999 Feb; 162(3):1641-7. PubMed ID: 9973424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemokine CXCL10 and Coronavirus-Induced Neurologic Disease.
    Skinner D; Marro BS; Lane TE
    Viral Immunol; 2019; 32(1):25-37. PubMed ID: 30109979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective Humoral Immunity in the Central Nervous System Requires Peripheral CD19-Dependent Germinal Center Formation following Coronavirus Encephalomyelitis.
    Atkinson JR; Bergmann CC
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impaired T cell immunity in B cell-deficient mice following viral central nervous system infection.
    Bergmann CC; Ramakrishna C; Kornacki M; Stohlman SA
    J Immunol; 2001 Aug; 167(3):1575-83. PubMed ID: 11466379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of T cells expanded in vivo during primary mouse hepatitis virus infection in mice.
    Kyuwa S; Machii K; Okumura A; Toyoda Y
    J Vet Med Sci; 1996 May; 58(5):431-7. PubMed ID: 8741603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD8+ T-cell epitopes within the surface glycoprotein of a neurotropic coronavirus and correlation with pathogenicity.
    Castro RF; Perlman S
    J Virol; 1995 Dec; 69(12):8127-31. PubMed ID: 7494335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.